117 related articles for article (PubMed ID: 11181905)
1. Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist.
Aiyar N; Daines RA; Disa J; Chambers PA; Sauermelch CF; Quiniou M; Khandoudi N; Gout B; Douglas SA; Willette RN
J Pharmacol Exp Ther; 2001 Mar; 296(3):768-75. PubMed ID: 11181905
[TBL] [Abstract][Full Text] [Related]
2. Volatile anesthetics inhibit calcitonin gene-related peptide receptor-mediated responses in pithed rats and human neuroblastoma cells.
Kuroda M; Yoshikawa D; Nishikawa K; Saito S; Goto F
J Pharmacol Exp Ther; 2004 Dec; 311(3):1016-22. PubMed ID: 15297469
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
Taylor CK; Smith DD; Hulce M; Abel PW
J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
[TBL] [Abstract][Full Text] [Related]
4. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of presynaptic calcitonin gene-related peptide (CGRP) receptors on CGRP-containing vasodilator nerves in rat mesenteric resistance vessels.
Nuki C; Kawasaki H; Takasaki K; Wada A
J Pharmacol Exp Ther; 1994 Jan; 268(1):59-64. PubMed ID: 7507998
[TBL] [Abstract][Full Text] [Related]
6. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
Pin SS; Xu C; Bahr BA
Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
[TBL] [Abstract][Full Text] [Related]
7. Studies on the effects of the N-terminal domain antibodies of calcitonin receptor-like receptor and receptor activity-modifying protein 1 on calcitonin gene-related peptide-induced vasorelaxation in rat uterine artery.
Chauhan M; Gangula PR; Wimalawansa SJ; Yallampalli C
Biol Reprod; 2004 Jun; 70(6):1658-63. PubMed ID: 14960487
[TBL] [Abstract][Full Text] [Related]
8. Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.
Sarau HM; Griswold DE; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Webb EF; Martin LD; Legos JJ; Whitmore RG; Barone FC; Medhurst AD; Luttmann MA; Giardina GA; Hay DW
J Pharmacol Exp Ther; 2000 Oct; 295(1):373-81. PubMed ID: 10992004
[TBL] [Abstract][Full Text] [Related]
9. Characterization of functional calcitonin gene-related peptide receptors on rat lymphocytes.
McGillis JP; Humphreys S; Reid S
J Immunol; 1991 Nov; 147(10):3482-9. PubMed ID: 1719079
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in calcitonin gene-related Peptide-induced relaxation in pregnant rat uterine artery.
Gangula PR; Thota C; Wimalawansa SJ; Bukoski RD; Yallampalli C
Biol Reprod; 2003 Nov; 69(5):1635-41. PubMed ID: 12855600
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
[TBL] [Abstract][Full Text] [Related]
12. CGRP and nitric oxide of neuronal origin and their involvement in neurogenic vasodilatation in rat skin microvasculature.
Merhi M; Dusting GJ; Khalil Z
Br J Pharmacol; 1998 Mar; 123(5):863-8. PubMed ID: 9535014
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a high-affinity and selective nonpeptide ETA receptor antagonist.
Ohlstein EH; Nambi P; Hay DW; Gellai M; Brooks DP; Luengo J; Xiang JN; Elliott JD
J Pharmacol Exp Ther; 1998 Aug; 286(2):650-6. PubMed ID: 9694916
[TBL] [Abstract][Full Text] [Related]
14. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
Holland PR; Akerman S; Goadsby PJ
J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
[TBL] [Abstract][Full Text] [Related]
15. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
16. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
Rist B; Entzeroth M; Beck-Sickinger AG
J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
[TBL] [Abstract][Full Text] [Related]
17. [Tyr0]-calcitonin gene-related peptide 28-37 (rat) as a putative antagonist of calcitonin gene-related peptide responses on opossum internal anal sphincter smooth muscle.
Chakder S; Rattan S
J Pharmacol Exp Ther; 1990 Apr; 253(1):200-6. PubMed ID: 2329508
[TBL] [Abstract][Full Text] [Related]
18. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
[TBL] [Abstract][Full Text] [Related]
19. Effect of two novel CGRP-binding compounds in a closed cranial window rat model.
Juhl L; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2007 Jul; 567(1-2):117-24. PubMed ID: 17477918
[TBL] [Abstract][Full Text] [Related]
20. Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1.
Kono T; Koseki T; Chiba S; Ebisawa Y; Chisato N; Iwamoto J; Kasai S
J Surg Res; 2008 Nov; 150(1):78-84. PubMed ID: 18561951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
